Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Jun;13(6):965–968. doi: 10.1128/aac.13.6.965

Therapeutic Failures with Miconazole

John F Fisher , Richard J Duma 1, Sheldon M Markowitz 1, Smith Shadomy 1, Ana Espinel-Ingroff 1, William H Chew 2
PMCID: PMC352371  PMID: 354523

Abstract

A retrospective review of therapeutic failures of miconazole in three patients is presented. Miconazole, a new imidazole derivative, is a broad-spectrum antifungal agent purportedly effective topically, orally, and parenterally against a number of species of fungi. Three patients with the following culturally proven deep fungal infections were treated with miconazole: (i) destructive arthritis (Sporothrix schenckii), (ii) meningoencephalitis (Cryptococcus neoformans), and (iii) disseminated aspergillosis (Aspergillus fumigatus). All the organisms were susceptible in vitro to 1.56 μg or less of miconazole per ml using a broth dilution technique. In each patient, miconazole administered intravenously in dosages of 30 mg/kg per day failed to control or eradicate infection. Miconazole serum levels ranged from <0.5 to 4.35 μg/ml as determined by radial diffusion bioassay. Cerebrospinal fluid levels were virtually undetectable. In one patient (C. neoformans), miconazole was given intraventricularly in doses of 15 mg without response. Therapeutic failures were attributed to suboptimal body fluid levels of miconazole. The reason(s) for such low levels of activity was not clear, but may have been poor penetrance into tissues, in vitro inactivation, and/or unusually rapid excretion. Untoward reactions from miconazole included fever, chills, nausea, vomiting, and phlebitis.

Full text

PDF
965

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Espinel-Ingroff A., Shadomy S., Fisher J. F. Bioassay for miconazole. Antimicrob Agents Chemother. 1977 Feb;11(2):365–368. doi: 10.1128/aac.11.2.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hoeprich P. D., Goldstein E. Miconazole therapy for coccidioidomycosis. JAMA. 1974 Nov 25;230(8):1153–1157. [PubMed] [Google Scholar]
  3. Levine H. B., Stevens D. A., Cobb J. M., Gebhardt A. E. Miconazole in coccidioidomycosis. I. Assays of activity in mice and in vitro. J Infect Dis. 1975 Oct;132(4):407–414. doi: 10.1093/infdis/132.4.407. [DOI] [PubMed] [Google Scholar]
  4. Stevens D. A., Levine H. B., Deresinski S. C. Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man. Am J Med. 1976 Feb;60(2):191–202. doi: 10.1016/0002-9343(76)90428-9. [DOI] [PubMed] [Google Scholar]
  5. Van Cutsem J. M., Thienpont D. Miconazole, a broad-spectrum antimycotic agent with antibacterial activity. Chemotherapy. 1972;17(6):392–404. doi: 10.1159/000220875. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES